Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
HemaSphere (2021) Vol. 5, Iss. 11, pp. e646-e646
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2493
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1634
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 140
Anaphylaxis: A 2023 practice parameter update
David B.K. Golden, Julie Wang, Susan Waserman, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 2, pp. 124-176
Open Access | Times Cited: 87
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 57
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1941-1950
Open Access | Times Cited: 57
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1999-2012.e6
Open Access | Times Cited: 47
Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond
Joana Vitte, Shamila Vibhushan, Manuela Bratti, et al.
Medical Principles and Practice (2022) Vol. 31, Iss. 6, pp. 501-515
Open Access | Times Cited: 41
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy
Peter Valent, Cem Akin, Wolfgang R. Sperr, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 361-386
Open Access | Times Cited: 40
Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases
Martin Metz, Pavel Kolkhir, Sabine Altrichter, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 37-51
Open Access | Times Cited: 30
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 26
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3010-3020
Open Access | Times Cited: 26
Interdisziplinäres, kollaboratives D-A-CH Konsensus-Statement zur Diagnostik und Behandlung von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom
Kathryn Hoffmann, Astrid Hainzl, Michael Stingl, et al.
Wiener klinische Wochenschrift (2024) Vol. 136, Iss. S5, pp. 103-123
Open Access | Times Cited: 8
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study
M. Jørgensen, Andreas Kiesbye Øvlisen, Jonas Jensen, et al.
European Journal of Epidemiology (2025)
Open Access | Times Cited: 1
Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation
Ernesto Aitella, Ciro Romano, Lia Ginaldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 927-927
Open Access | Times Cited: 1
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
Andreas Reiter, Jason Gotlib, Iván Álvarez‐Twöse, et al.
Leukemia (2022) Vol. 36, Iss. 8, pp. 2108-2120
Open Access | Times Cited: 35
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions
Jonathan J. Lyons, Georg Greiner, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1964-1973
Open Access | Times Cited: 28
Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis
Mark Kačar, Matija Rijavec, Julij Šelb, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 4, pp. 392-404
Open Access | Times Cited: 21
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Roberta Parente, Valentina Giudice, Chiara Cardamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7071-7071
Open Access | Times Cited: 17
Challenges in the Diagnosis of Cutaneous Mastocytosis
Knut Brockow, Rebekka K. Bent, Simon Schneider, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 161-161
Open Access | Times Cited: 7
High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need Hymenoptera venom immunotherapy
Peter Korošec, Gunter J. Sturm, Jonathan J. Lyons, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2458-2469
Open Access | Times Cited: 7
Using the Right Criteria for MCAS
Theo Gülen
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 2, pp. 39-51
Open Access | Times Cited: 6
Clinical relevance of inherited genetic differences in human tryptases
Sarah C. Glover, Melody C. Carter, Peter Korošec, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 127, Iss. 6, pp. 638-647
Open Access | Times Cited: 38
Avapritinib for advanced systemic mastocytosis
Jason Gotlib, Andreas Reiter, Daniel J. DeAngelo
Blood (2022) Vol. 140, Iss. 15, pp. 1667-1673
Closed Access | Times Cited: 27
The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors
Weijie Li
Leukemia (2022), pp. 1-21
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top